Log in to save to my catalogue

Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular car...

Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular car...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_34d2858ad5d442d290bd1f7f71d116e8

Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

About this item

Full title

Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Publisher

Korea (South): Korean Association for the Study of the Liver

Journal title

Clinical and molecular hepatology, 2024-07, Vol.30 (3), p.436-448

Language

English

Formats

Publication information

Publisher

Korea (South): Korean Association for the Study of the Liver

More information

Scope and Contents

Contents

Background/Aims: The global proportion of hepatocellular carcinoma (HCC) attributable to metabolic dysfunction-associated fatty liver disease (MAFLD) is unclear. The MAFLD diagnostic criteria allows objective diagnosis in the presence of steatosis plus defined markers of metabolic dysfunction, irrespective of concurrent liver disease. We aimed to d...

Alternative Titles

Full title

Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_34d2858ad5d442d290bd1f7f71d116e8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_34d2858ad5d442d290bd1f7f71d116e8

Other Identifiers

ISSN

2287-2728,2287-285X

E-ISSN

2287-285X

DOI

10.3350/cmh.2024.0109

How to access this item